421. [Oral mucositis, stomatitis--oral management of cancer patients receiving chemotherapy].422. [Chemotherapy-induced nausea, vomiting and diarrhea].423. [Appetite loss].424. [Thrombocytopenia].425. [Anemia].426. [Appropriate use of granulocyte-colony stimulating factor].427. [Febrile neutropenia].428. [Toxicity of aromatase inhibitor].429. [Mechanism and side effect of endocrine therapy].430. [Side effects of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)].431. [Anti-vascular endothelial growth factor antibody].432. [Action mechanisms of molecular target agents and their off-target toxicities; introduction].434. [Antileukemic].435. [Topoisomerase II interactive agents (except for anthracyclins)].436. [Topoisomerase II inhibitors (anthracyclines)].437. [DNA topoisomerase I--targeting drugs].439. [Adverse effects of antimetabolite fluoropyrimidine analog]. |